Use of vasopressin antagonists in human diseases
Thibonnier, M.
Kidney International. Suppl 26: S48-S51
1988
ISSN/ISBN: 0098-6577 PMID: 2974097 Document Number: 315063
Document emailed within 1 workday
Related Documents
Jard, S.; Gaillard, R.C.; Guillon, G.; Marie, J.; Schoenenberg, P.; Muller, A.F.; Manning, M.; Sawyer, W.H. 1986: Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis Molecular Pharmacology 30(2): 171-177Jard, S. 1988: Mechanisms of action of vasopressin and vasopressin antagonists Kidney International. Suppl 26: S38-S42
Sawyer, W.H.; Manning, M. 1985: The use of antagonists of vasopressin in studies of its physiological functions Federation Proceedings 44(1 Part 1): 78-80
2003: Heart failure. Can vasopressin antagonists improve the prognosis? MMW Fortschritte der Medizin 145(48): 10
Akerlund, M.; Melin, P.; Maggi, M. 1995: Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea Advances in Experimental Medicine and Biology 395: 595-600
Schück, O.; Cort, J.H.; Stríbrná, J.; Skopková, J.; Jost, K. 1975: A new synthetic analog of vasopressin, desamino-6 carba-(8-D-arginin)-vasopressin, active against diabetes insipidus refractory to vasopressin and adiuretin spofa Casopis Lekaru Ceskych 114(6): 172-175
Stassen, F.L.; Heckman, G.D.; Huffman, W.F.; Kinter, L.B. 1985: Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla Journal of Pharmacology and Experimental Therapeutics 232(1): 100-105
Derkx, F.H.; Man in 't Veld, A.J.; Jones, R.; Reid, J.L.; Schalekamp, M.A. 1983: DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1(2): 58-61
Tamas, G.; Chatel, R. 1975: Powdered lysine-vasopressin (vasopressin spray) in the treatment of diabetes insipidus Orvosi Hetilap 116(4): 191-194
Brinton, R.E.; Buck, S.H.; Deshmukh, P.P.; Hsiao, S.; Yamamura, H.I. 1982: Radioimmunoassay of vasopressin: development and application to the measurement of intra- and extra-hypothalamic vasopressin levels in the rat Proceedings of the Western Pharmacology Society 25: 73-74
Ebenezer, I.S. 1994: The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors Methods and Findings in Experimental and Clinical Pharmacology 16(5): 315-321
Gubitz, G.J.; Naylor, A.M.; Veale, W.L. 1987: Mechanism of vasopressin induced antipyresis: effects of cool and warm environments on the thermoregulatory actions of central vasopressin Proceedings of the Western Pharmacology Society 30: 253-257
Lumholtz, I.B. 1977: Drug information. Therapeutic main group: antidiuretics. Preparation DDAVP (deamino arginine vasopressin); Minurin, Lypressinum; Insipid retard; Vasopressin Sygeplejersken 77(30): 21
Weiskopf, R.B.; Reid, I.A.; Fisher, D.M.; Holmes, M.A.; Rosen, J.I.; Keil, L.C. 1987: Effects of fentanyl on vasopressin secretion in human subjects Journal of Pharmacology and Experimental Therapeutics 242(3): 970-973
Taylor, A.H.; Ang, V.T.; Jenkins, J.S.; Silverlight, J.J.; Coombes, R.C.; Luqmani, Y.A. 1990: Interaction of vasopressin and oxytocin with human breast carcinoma cells Cancer Research 50(24): 7882-7886
Swaab, D.F.; Fliers, E.; Fisser, B. 1985: The vasopressin containing neurons in the human brain; changes during ageing and senile dementia British Journal of Clinical Practice. Suppl 39: 7-10
Medina, P.; Noguera, I.; Aldasoro, M.; Vila, J.M.; Flor, B.; Lluch, S. 1997: Enhancement by vasopressin of adrenergic responses in human mesenteric arteries American Journal of Physiology 272(3 Pt 2): H1087-H1093
Spinar, J.; Vítovec, J. 2012: AIi antagonists (candesartan and irbesartan) in the treatment of cardiovascular diseases Vnitrni Lekarstvi 58(10): 755-760
Maton, P.N.; Jensen, R.T. 1992: Use of gut peptide receptor agonists and antagonists in gastrointestinal diseases Gastroenterology Clinics of North America 21(3): 551-566
Mayerhofer, S. 1986: Mechanism of action of calcium antagonists in the treatment of vascular diseases Wiener Medizinische Wochenschrift 136(21-22): 591-594